Categories: Manufacturers (D)

Sterling biotech Ltd, C – 25, Laxmi Towers, ‘A’ – 601, 6th Floor, Bandra Kurla Complex, Bandra (East) Mumbai – 400051

Company Name : Sterling biotech Ltd

Address : C – 25, Laxmi Towers, ‘A’ – 601, 6th Floor, Bandra Kurla Complex, Bandra (East) Mumbai – 400051

Tel No : 91-22-26541241/42/43

Email : apisales@sterbio.com

Website : http://www.sterlingbiotech.in/

Company Profile

Working with and developing any opportunity into reality is a mindset at Sterling Group. Sterling with its new thinking, new capabilities and sense of urgency aspires to “Earn trust, every moment” of its partners, collaborators, stake holders and customers. At Sterling Biotech Ltd. our goal is to commercialize Active Pharmaceutical Ingredient and make it available at competitive prices to our global customers.

 

Our capabilities include state of art research centre, advance pilot plant for scale up studies, modern facility of bioreactors and range of down streaming process equipments. All these are coupled with dedicated and qualified work force, well equipped quality control laboratory and quality assurance systems

 

We strive to become leaders in API pharmaceutical area by developing state of the art facility for research and development, contract manufacturing of active pharmaceutical ingredients. We build quality in every aspect of manufacturing with particular laid down emphasis based on current Good Manufacturing Practices.

 

Sterling Biotech Ltd. is committed to scaling new heights and creating new dimensions in Fermentation based API and Synthetic API . This way we shall support aspiration to “Live better and Live longer”.

 

Sterling Biotech’s manufacturing facility at Masar, Gujarat, is at par with international standards. It complies with cGMP norms complying to the standards of WHO and is in the process of getting CEP for the active pharmaceutical ingredient Epirubicin , Lovastatin

 

This adequately reflects Sterlings commitment towards quality. Efforts to attain such standards have also opened the key to gain foothold in the regulated and semi regulated markets throughout US and Europe

The Pharma Times News Bureau

Recent Posts

Gleneagles Hospital Mumbai Introduces Pediatric Bone Marrow Transplant (BMT) Facility

New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…

2 days ago

Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT);

Achieves significant advancement in Cancer Treatment to Enhance Quality of Life  As per the National…

3 days ago

Two Complex Robotic Kidney Transplant Surgeries Successfully Performed at Fortis Hospital Bannerghatta Road

-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…

4 days ago

On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology Nurses

Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…

5 days ago

SOCC Unveils A New Era In Paediatric Care: Second Opinion Online Consultations For Children

Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…

1 week ago

India’s First Lady Surgeon Trained in Robotic Breast Surgery Performs Karnataka’s 1st Robotic Nipple Sparing Mastectomy

Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…

2 weeks ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420